Back to News
Market Impact: 0.25
SQZ Biotechnologies Consensus Price Target Decreased by 50.00% to $22.44
Source: Nasdaq
Analyst EstimatesHealthcare & Biotech
The average one-year price target for SQZ Biotechnologies was revised down 50.00% to $22.44 per share from $44.88 on October 31, 2023. The article attributes the figures to aggregate analyst target consensus; it provides no share-price reaction or further explanation.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
More News
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
- Why is Apple stock falling afterhours today?
- RA Capital Management sells $9.13M in Lenz Therapeutics shares
- Karyopharm stock rating cut to neutral by Rodman on bankruptcy
- Vornado earnings missed by $0.12, revenue fell short of estimates